The issues brought up in Petryna’s article about international
clinical trials were featured recently in a New York Times article titled “Russians Eagerly Participate in Medical
Experiments, Despite Risks” which was published on September 26th. The article discusses how, in 2010, the government passed a
law to require the testing of pharmaceuticals in Russia in order for the drugs
to be marketed within the country. This has been part of Putin and the Russian
government’s plans to encourage clinical trials to locate their studies in
Russia. These programs have worked and the latest number of trials approved
within a six-month period has more than doubled. While these clinical trials often
bring with them economic and health benefits to Russia (for many it’s the only
means they have to access modern health care), critics point to issues of
questionable ethical behavior and the unscientific nature of some trials which can
lead to many negative outcomes for patients.
I was impressed by the actions of some of the people featured in this article who continue to willingly participate in these trials even after facing adverse results. One elderly woman " threw up every day for two weeks, yet stuck to the regimen" while undergoing a weight-loss procedure which required injecting herself in the stomach daily. One doctor reported an experimental trial in which participants experienced a rapid allergic reaction, "Red dots started appearing all over, right in front of my eyes. They appeared in just a few minutes. It was really shocking".
http://www.nytimes.com/2012/09/27/business/global/russians-eagerly-participating-in-medical-experiments-despite-risks.html?pagewanted=all&_r=0
No comments:
Post a Comment